First National Bank Of South Miami Regeneron Pharmaceuticals, Inc. Transaction History

First National Bank Of South Miami

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $4,591 - $5,794	-8 Reduced 53.33%	7 $5,000
Q2 2022 Jul 13, 2022	SELL	$548.35 - $738.84 $29,062 - $39,158	-53 Reduced 77.94%	15 $9,000
Q1 2022 Apr 08, 2022	SELL	$595.12 - $698.43 $82,126 - $96,383	-138 Reduced 66.99%	68 $47,000
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $31,521 - $38,916	58 Added 39.19%	206 $130,000
Q3 2021 Oct 07, 2021	BUY	$574.03 - $680.96 $84,956 - $100,782	148 New	148 $90,000
Q1 2021 May 11, 2021	SELL	$446.73 - $548.2 $4,467 - $5,482	-10 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3,361 - $4,944	10 New	10 $5,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of First National Bank Of South Miami, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of South Miami with notifications on news.